Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study
- PMID: 31083728
- DOI: 10.7326/M18-2772
Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study
Abstract
Background: Blood cultures, the gold standard for diagnosing bloodstream infections (BSIs), are insensitive and limited by prolonged time to results. The T2Bacteria Panel (T2 Biosystems) is a direct-from-blood, nonculture test that identifies the most common ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli).
Objective: To assess performance of the T2Bacteria Panel in diagnosing suspected BSIs in adults.
Design: Prospective patient enrollment (8 December 2015 through 4 August 2017).
Setting: Eleven U.S. hospitals.
Patients: 1427 patients for whom blood cultures were ordered as standard of care.
Intervention: Paired blood culture and T2Bacteria testing.
Measurements: Performance of T2Bacteria compared with a single set of blood cultures in diagnosing proven, probable, and possible BSIs caused by T2Bacteria-targeted organisms.
Results: Blood culture and T2Bacteria results were positive for targeted bacteria in 3% (39 of 1427) and 13% (181 of 1427) of patients, respectively. Mean times from start of blood culture incubation to positivity and species identification were 38.5 (SD, 32.8) and 71.7 (SD, 39.3) hours, respectively. Mean times to species identification with T2Bacteria were 3.61 (SD, 0.2) to 7.70 (SD, 1.38) hours, depending on the number of samples tested. Per-patient sensitivity and specificity of T2Bacteria for proven BSIs were 90% (95% CI, 76% to 96%) and 90% (CI, 88% to 91%), respectively; the negative predictive value was 99.7% (1242 of 1246). The rate of negative blood cultures with a positive T2Bacteria result was 10% (146 of 1427); 60% (88 of 146) of such results were associated with probable (n = 62) or possible (n = 26) BSIs. If probable BSIs and both probable and possible BSIs were assumed to be true positives missed by blood culture, per-patient specificity of T2Bacteria was 94% and 96%, respectively.
Limitation: Low prevalence of positive blood cultures, collection of a single set of culture specimens, and inability of T2Bacteria to detect nontargeted pathogens.
Conclusion: The T2Bacteria Panel rapidly and accurately diagnoses BSIs caused by 5 common bacteria.
Primary funding source: T2 Biosystems.
Comment in
-
The Uncertain Clinical Benefit of the T2Bacteria Panel.Ann Intern Med. 2019 Jun 18;170(12):888-889. doi: 10.7326/M19-0971. Epub 2019 May 14. Ann Intern Med. 2019. PMID: 31083723 No abstract available.
-
The T2Bacteria Panel had 90% sensitivity for detecting targeted organisms, 43% for any bloodstream infection organism.Ann Intern Med. 2019 Sep 17;171(6):JC34. doi: 10.7326/ACPJ201909170-034. Ann Intern Med. 2019. PMID: 31525768 No abstract available.
Similar articles
-
In-depth analysis of T2Bacteria positive results in patients with concurrent negative blood culture: a case series.BMC Infect Dis. 2020 May 7;20(1):326. doi: 10.1186/s12879-020-05049-9. BMC Infect Dis. 2020. PMID: 32380973 Free PMC article. Clinical Trial.
-
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood.J Antimicrob Chemother. 2018 Mar 1;73(suppl_4):iv20-iv26. doi: 10.1093/jac/dky049. J Antimicrob Chemother. 2018. PMID: 29608753
-
The T2Bacteria Assay Is a Sensitive and Rapid Detector of Bacteremia That Can Be Initiated in the Emergency Department and Has Potential to Favorably Influence Subsequent Therapy.J Emerg Med. 2020 May;58(5):785-796. doi: 10.1016/j.jemermed.2019.11.028. Epub 2020 Jan 23. J Emerg Med. 2020. PMID: 31982197
-
Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches.Clin Microbiol Infect. 2018 Sep;24(9):944-955. doi: 10.1016/j.cmi.2018.05.007. Epub 2018 May 19. Clin Microbiol Infect. 2018. PMID: 29787889 Review.
-
Identifying and classifying bloodstream infections among hemodialysis patients.Semin Dial. 2013 Jul-Aug;26(4):407-15. doi: 10.1111/sdi.12092. Epub 2013 Apr 18. Semin Dial. 2013. PMID: 23594181 Review.
Cited by
-
Assessing sepsis-induced immunosuppression to predict positive blood cultures.Front Immunol. 2024 Nov 4;15:1447523. doi: 10.3389/fimmu.2024.1447523. eCollection 2024. Front Immunol. 2024. PMID: 39559359 Free PMC article.
-
Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis.Microorganisms. 2024 Sep 3;12(9):1824. doi: 10.3390/microorganisms12091824. Microorganisms. 2024. PMID: 39338498 Free PMC article. Review.
-
Evaluation of T2 Magnetic Resonance (T2MR®) Technology for the Early Detection of ESKAPEc Pathogens in Septic Patients.Antibiotics (Basel). 2024 Sep 14;13(9):885. doi: 10.3390/antibiotics13090885. Antibiotics (Basel). 2024. PMID: 39335058 Free PMC article.
-
Performance of T2Bacteria in relationship to blood cultures - a retrospective comparative study.Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):1977-1987. doi: 10.1007/s10096-024-04916-6. Epub 2024 Aug 3. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39096321 Free PMC article.
-
From Species to Genes: A New Diagnostic Paradigm.Antibiotics (Basel). 2024 Jul 17;13(7):661. doi: 10.3390/antibiotics13070661. Antibiotics (Basel). 2024. PMID: 39061343 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources